Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares

by NASDAQ Market News December 16, 2019

NASDAQ Market News
Click here to email author

Aptose Announces Proposed Public Offering of Common Shares

Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation

Ads